ギランバレー症候群治療薬の世界市場（～2026年）

• 英文タイトル：Global Guillain-Barre Syndrome Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07010 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はギランバレー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（余矢、免疫グロブリン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ギランバレー症候群治療薬の競争状況、市場シェア ・世界のギランバレー症候群治療薬市場：種類別市場規模 2015年-2020年（余矢、免疫グロブリン、その他） ・世界のギランバレー症候群治療薬市場：種類別市場規模予測 2021年-2026年（余矢、免疫グロブリン、その他） ・世界のギランバレー症候群治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のギランバレー症候群治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のギランバレー症候群治療薬市場分析：米国、カナダ ・ヨーロッパのギランバレー症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのギランバレー症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のギランバレー症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのギランバレー症候群治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Akari Therapeutics Plc、Annexon Inc、CuraVac Inc、Hansa Medical AB、Regenesance BV、Vitality Biopharma Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Guillain-Barre Syndrome Drugs Market
The global Guillain-Barre Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Guillain-Barre Syndrome Drugs Scope and Market Size
Guillain-Barre Syndrome Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Guillain-Barre Syndrome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Guillain-Barre Syndrome Drugs market is segmented into
Coversin
Immune Globulin
Others

Segment by Application, the Guillain-Barre Syndrome Drugs market is segmented into
Clinic
Hospital
Others

Regional and Country-level Analysis
The Guillain-Barre Syndrome Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Guillain-Barre Syndrome Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Guillain-Barre Syndrome Drugs Market Share Analysis
Guillain-Barre Syndrome Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Guillain-Barre Syndrome Drugs business, the date to enter into the Guillain-Barre Syndrome Drugs market, Guillain-Barre Syndrome Drugs product introduction, recent developments, etc.

The major vendors covered:
Akari Therapeutics Plc
Annexon Inc
CuraVac Inc
Hansa Medical AB
Regenesance BV
Vitality Biopharma Inc
…

レポート目次

---

1 Study Coverage
1.1 Guillain-Barre Syndrome Drugs Product Introduction
1.2 Market Segments
1.3 Key Guillain-Barre Syndrome Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Guillain-Barre Syndrome Drugs Market Size Growth Rate by Type
1.4.2 Coversin
1.4.3 Immune Globulin
1.4.4 Others
1.5 Market by Application
1.5.1 Global Guillain-Barre Syndrome Drugs Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Guillain-Barre Syndrome Drugs Market Size, Estimates and Forecasts
2.1.1 Global Guillain-Barre Syndrome Drugs Revenue 2015-2026
2.1.2 Global Guillain-Barre Syndrome Drugs Sales 2015-2026
2.2 Global Guillain-Barre Syndrome Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Guillain-Barre Syndrome Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Guillain-Barre Syndrome Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Guillain-Barre Syndrome Drugs Competitor Landscape by Players
3.1 Guillain-Barre Syndrome Drugs Sales by Manufacturers
3.1.1 Guillain-Barre Syndrome Drugs Sales by Manufacturers (2015-2020)
3.1.2 Guillain-Barre Syndrome Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Guillain-Barre Syndrome Drugs Revenue by Manufacturers
3.2.1 Guillain-Barre Syndrome Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Guillain-Barre Syndrome Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Guillain-Barre Syndrome Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Guillain-Barre Syndrome Drugs Revenue in 2019
3.2.5 Global Guillain-Barre Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Guillain-Barre Syndrome Drugs Price by Manufacturers
3.4 Guillain-Barre Syndrome Drugs Manufacturing Base Distribution, Product Types
3.4.1 Guillain-Barre Syndrome Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Guillain-Barre Syndrome Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Guillain-Barre Syndrome Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Guillain-Barre Syndrome Drugs Market Size by Type (2015-2020)
4.1.1 Global Guillain-Barre Syndrome Drugs Sales by Type (2015-2020)
4.1.2 Global Guillain-Barre Syndrome Drugs Revenue by Type (2015-2020)
4.1.3 Guillain-Barre Syndrome Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Guillain-Barre Syndrome Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Guillain-Barre Syndrome Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Guillain-Barre Syndrome Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Guillain-Barre Syndrome Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Guillain-Barre Syndrome Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Guillain-Barre Syndrome Drugs Market Size by Application (2015-2020)
5.1.1 Global Guillain-Barre Syndrome Drugs Sales by Application (2015-2020)
5.1.2 Global Guillain-Barre Syndrome Drugs Revenue by Application (2015-2020)
5.1.3 Guillain-Barre Syndrome Drugs Price by Application (2015-2020)
5.2 Guillain-Barre Syndrome Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Guillain-Barre Syndrome Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Guillain-Barre Syndrome Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Guillain-Barre Syndrome Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Guillain-Barre Syndrome Drugs by Country
6.1.1 North America Guillain-Barre Syndrome Drugs Sales by Country
6.1.2 North America Guillain-Barre Syndrome Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Guillain-Barre Syndrome Drugs Market Facts & Figures by Type
6.3 North America Guillain-Barre Syndrome Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Guillain-Barre Syndrome Drugs by Country
7.1.1 Europe Guillain-Barre Syndrome Drugs Sales by Country
7.1.2 Europe Guillain-Barre Syndrome Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Guillain-Barre Syndrome Drugs Market Facts & Figures by Type
7.3 Europe Guillain-Barre Syndrome Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Guillain-Barre Syndrome Drugs by Region
8.1.1 Asia Pacific Guillain-Barre Syndrome Drugs Sales by Region
8.1.2 Asia Pacific Guillain-Barre Syndrome Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Guillain-Barre Syndrome Drugs Market Facts & Figures by Type
8.3 Asia Pacific Guillain-Barre Syndrome Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Guillain-Barre Syndrome Drugs by Country
9.1.1 Latin America Guillain-Barre Syndrome Drugs Sales by Country
9.1.2 Latin America Guillain-Barre Syndrome Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Guillain-Barre Syndrome Drugs Market Facts & Figures by Type
9.3 Central & South America Guillain-Barre Syndrome Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Guillain-Barre Syndrome Drugs by Country
10.1.1 Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country
10.1.2 Middle East and Africa Guillain-Barre Syndrome Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Guillain-Barre Syndrome Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Guillain-Barre Syndrome Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Akari Therapeutics Plc
11.1.1 Akari Therapeutics Plc Corporation Information
11.1.2 Akari Therapeutics Plc Description and Business Overview
11.1.3 Akari Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Products Offered
11.1.5 Akari Therapeutics Plc Related Developments
11.2 Annexon Inc
11.2.1 Annexon Inc Corporation Information
11.2.2 Annexon Inc Description and Business Overview
11.2.3 Annexon Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Annexon Inc Guillain-Barre Syndrome Drugs Products Offered
11.2.5 Annexon Inc Related Developments
11.3 CuraVac Inc
11.3.1 CuraVac Inc Corporation Information
11.3.2 CuraVac Inc Description and Business Overview
11.3.3 CuraVac Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CuraVac Inc Guillain-Barre Syndrome Drugs Products Offered
11.3.5 CuraVac Inc Related Developments
11.4 Hansa Medical AB
11.4.1 Hansa Medical AB Corporation Information
11.4.2 Hansa Medical AB Description and Business Overview
11.4.3 Hansa Medical AB Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hansa Medical AB Guillain-Barre Syndrome Drugs Products Offered
11.4.5 Hansa Medical AB Related Developments
11.5 Regenesance BV
11.5.1 Regenesance BV Corporation Information
11.5.2 Regenesance BV Description and Business Overview
11.5.3 Regenesance BV Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regenesance BV Guillain-Barre Syndrome Drugs Products Offered
11.5.5 Regenesance BV Related Developments
11.6 Vitality Biopharma Inc
11.6.1 Vitality Biopharma Inc Corporation Information
11.6.2 Vitality Biopharma Inc Description and Business Overview
11.6.3 Vitality Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Products Offered
11.6.5 Vitality Biopharma Inc Related Developments
11.1 Akari Therapeutics Plc
11.1.1 Akari Therapeutics Plc Corporation Information
11.1.2 Akari Therapeutics Plc Description and Business Overview
11.1.3 Akari Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Products Offered
11.1.5 Akari Therapeutics Plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Guillain-Barre Syndrome Drugs Market Estimates and Projections by Region
12.1.1 Global Guillain-Barre Syndrome Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Guillain-Barre Syndrome Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Guillain-Barre Syndrome Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Guillain-Barre Syndrome Drugs Sales Forecast (2021-2026)
12.2.2 North America: Guillain-Barre Syndrome Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Guillain-Barre Syndrome Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Guillain-Barre Syndrome Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Guillain-Barre Syndrome Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Guillain-Barre Syndrome Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Guillain-Barre Syndrome Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Guillain-Barre Syndrome Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Guillain-Barre Syndrome Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Guillain-Barre Syndrome Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Guillain-Barre Syndrome Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Guillain-Barre Syndrome Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Guillain-Barre Syndrome Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Guillain-Barre Syndrome Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Guillain-Barre Syndrome Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Guillain-Barre Syndrome Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Guillain-Barre Syndrome Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Guillain-Barre Syndrome Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Guillain-Barre Syndrome Drugs Market Segments
Table 2. Ranking of Global Top Guillain-Barre Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Guillain-Barre Syndrome Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Coversin
Table 5. Major Manufacturers of Immune Globulin
Table 6. Major Manufacturers of Others
Table 7. Global Guillain-Barre Syndrome Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Guillain-Barre Syndrome Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Guillain-Barre Syndrome Drugs Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Guillain-Barre Syndrome Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Guillain-Barre Syndrome Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Guillain-Barre Syndrome Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Guillain-Barre Syndrome Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Guillain-Barre Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Guillain-Barre Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guillain-Barre Syndrome Drugs as of 2019)
Table 16. Guillain-Barre Syndrome Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Guillain-Barre Syndrome Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Guillain-Barre Syndrome Drugs Price (2015-2020) (USD/Pcs)
Table 19. Guillain-Barre Syndrome Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Guillain-Barre Syndrome Drugs Product Type
Table 21. Date of International Manufacturers Enter into Guillain-Barre Syndrome Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 24. Global Guillain-Barre Syndrome Drugs Sales Share by Type (2015-2020)
Table 25. Global Guillain-Barre Syndrome Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Guillain-Barre Syndrome Drugs Revenue Share by Type (2015-2020)
Table 27. Guillain-Barre Syndrome Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 29. Global Guillain-Barre Syndrome Drugs Sales Share by Application (2015-2020)
Table 30. North America Guillain-Barre Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 31. North America Guillain-Barre Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Guillain-Barre Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Guillain-Barre Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 35. North America Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 37. North America Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Guillain-Barre Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Guillain-Barre Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Guillain-Barre Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Guillain-Barre Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Guillain-Barre Syndrome Drugs Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Guillain-Barre Syndrome Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Guillain-Barre Syndrome Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Guillain-Barre Syndrome Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Guillain-Barre Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Guillain-Barre Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Guillain-Barre Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Guillain-Barre Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Guillain-Barre Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Guillain-Barre Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Guillain-Barre Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Table 70. Akari Therapeutics Plc Corporation Information
Table 71. Akari Therapeutics Plc Description and Major Businesses
Table 72. Akari Therapeutics Plc Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Akari Therapeutics Plc Product
Table 74. Akari Therapeutics Plc Recent Development
Table 75. Annexon Inc Corporation Information
Table 76. Annexon Inc Description and Major Businesses
Table 77. Annexon Inc Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Annexon Inc Product
Table 79. Annexon Inc Recent Development
Table 80. CuraVac Inc Corporation Information
Table 81. CuraVac Inc Description and Major Businesses
Table 82. CuraVac Inc Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. CuraVac Inc Product
Table 84. CuraVac Inc Recent Development
Table 85. Hansa Medical AB Corporation Information
Table 86. Hansa Medical AB Description and Major Businesses
Table 87. Hansa Medical AB Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Hansa Medical AB Product
Table 89. Hansa Medical AB Recent Development
Table 90. Regenesance BV Corporation Information
Table 91. Regenesance BV Description and Major Businesses
Table 92. Regenesance BV Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Regenesance BV Product
Table 94. Regenesance BV Recent Development
Table 95. Vitality Biopharma Inc Corporation Information
Table 96. Vitality Biopharma Inc Description and Major Businesses
Table 97. Vitality Biopharma Inc Guillain-Barre Syndrome Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Vitality Biopharma Inc Product
Table 99. Vitality Biopharma Inc Recent Development
Table 100. Global Guillain-Barre Syndrome Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 101. Global Guillain-Barre Syndrome Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Guillain-Barre Syndrome Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Guillain-Barre Syndrome Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Guillain-Barre Syndrome Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. North America: Guillain-Barre Syndrome Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Guillain-Barre Syndrome Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Europe: Guillain-Barre Syndrome Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Guillain-Barre Syndrome Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 109. Asia Pacific: Guillain-Barre Syndrome Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Guillain-Barre Syndrome Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Latin America: Guillain-Barre Syndrome Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Guillain-Barre Syndrome Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Middle East and Africa: Guillain-Barre Syndrome Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Guillain-Barre Syndrome Drugs Players
Table 118. Guillain-Barre Syndrome Drugs Customers List
Table 119. Guillain-Barre Syndrome Drugs Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Guillain-Barre Syndrome Drugs Product Picture
Figure 2. Global Guillain-Barre Syndrome Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Coversin Product Picture
Figure 4. Immune Globulin Product Picture
Figure 5. Others Product Picture
Figure 6. Global Guillain-Barre Syndrome Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Clinic
Figure 8. Hospital
Figure 9. Others
Figure 10. Guillain-Barre Syndrome Drugs Report Years Considered
Figure 11. Global Guillain-Barre Syndrome Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Guillain-Barre Syndrome Drugs Sales 2015-2026 (K Pcs)
Figure 13. Global Guillain-Barre Syndrome Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Guillain-Barre Syndrome Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Guillain-Barre Syndrome Drugs Sales Market Share by Region in 2019
Figure 16. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Region in 2019
Figure 18. Global Guillain-Barre Syndrome Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Guillain-Barre Syndrome Drugs Revenue in 2019
Figure 20. Guillain-Barre Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Guillain-Barre Syndrome Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Guillain-Barre Syndrome Drugs Sales Market Share by Type in 2019
Figure 23. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Type in 2019
Figure 25. Global Guillain-Barre Syndrome Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Guillain-Barre Syndrome Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Guillain-Barre Syndrome Drugs Sales Market Share by Application in 2019
Figure 28. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Guillain-Barre Syndrome Drugs Revenue Market Share by Application in 2019
Figure 30. North America Guillain-Barre Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Guillain-Barre Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Guillain-Barre Syndrome Drugs Sales Market Share by Country in 2019
Figure 33. North America Guillain-Barre Syndrome Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Guillain-Barre Syndrome Drugs Market Share by Type in 2019
Figure 39. North America Guillain-Barre Syndrome Drugs Market Share by Application in 2019
Figure 40. Europe Guillain-Barre Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Guillain-Barre Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Guillain-Barre Syndrome Drugs Sales Market Share by Country in 2019
Figure 43. Europe Guillain-Barre Syndrome Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Guillain-Barre Syndrome Drugs Market Share by Type in 2019
Figure 55. Europe Guillain-Barre Syndrome Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Guillain-Barre Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Guillain-Barre Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Guillain-Barre Syndrome Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Guillain-Barre Syndrome Drugs Revenue Market Share by Region in 2019
Figure 60. China Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Guillain-Barre Syndrome Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Guillain-Barre Syndrome Drugs Market Share by Application in 2019
Figure 84. Latin America Guillain-Barre Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Guillain-Barre Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Guillain-Barre Syndrome Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Guillain-Barre Syndrome Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Guillain-Barre Syndrome Drugs Market Share by Type in 2019
Figure 95. Latin America Guillain-Barre Syndrome Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Guillain-Barre Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Guillain-Barre Syndrome Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Guillain-Barre Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Guillain-Barre Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Guillain-Barre Syndrome Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Guillain-Barre Syndrome Drugs Market Share by Application in 2019
Figure 108. North America Guillain-Barre Syndrome Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Guillain-Barre Syndrome Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Guillain-Barre Syndrome Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Guillain-Barre Syndrome Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Guillain-Barre Syndrome Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Guillain-Barre Syndrome Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Guillain-Barre Syndrome Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Guillain-Barre Syndrome Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Guillain-Barre Syndrome Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Guillain-Barre Syndrome Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

---